The study of maternal serum biomarkers during perinatal period

The study of serum plasmatic biomarkers during perinatal period

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000034900

Enrollment

Unknown

Registered

2020-07-23

Start date

2020-07-23

Completion date

Unknown

Last updated

2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery (Perinatal period)

Interventions

cesarean section group:Nil

vaginal delivery gorup:Nil

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ASA I-II, primipara, singleton, full-term (37 Week or more), near labor but not entered the labor process.

Exclusion criteria

Exclusion criteria: Eclampsia, preeclampsia, hypertension requiring antihypertensive drugs, GDM requiring insulin, high risk factors of infection (including fever, premature rupture of membranes).

Design outcomes

Primary

Measure	Time frame
serum biomarkers;	—

Countries

China

Contacts

Public ContactZifeng Xu

The International Peace Maternity and Child Health Hospital, Shanghai Jiaotong University School of Medicine

xuzf@shsmu.edu.cn+86 021-64070434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026